Back to results
US 11,376,232 B2Granted
Vidofludimus for use in the treatment or prevention of viral diseases
AssigneeImmunic AG
InventorsManfred Gröppel, Daniel Vitt, Hella Kohlhof, Andreas Mühler
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound according to Formula (I) or a salt, solvate and/or a hydrate thereof, wherein said compound inhibits dihydroorotate dehydrogenase (DHODH), for use in the treatment and prevention of viral infection. A preferred example is viral infection caused by coronavirus, in particular betacoronavirus, more particular SARS-CoV-2 and mutated versions thereof.
Claims29
A method for treating a viral infection caused by a coronavirus in a mammalian subject comprising administering to said subject an effective amount of a DHODH inhibitor compound according to Formula (I),
- a pharmaceutically acceptable salt, a solvate, a solvate of a salt, or a hydrate thereof.
Dependencies are inferred from the claim text.